Search results
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 6 days agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome...
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 1 day agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
European Midday Briefing: Stocks, Euro Hit by European Political Upheaval
Morningstar· 3 days agoEuropean stocks fell on Monday after European elections resulted in strong gains for right-wing Euroskeptic parties, prompting Emmanuel Macron to call a snap election in France. The main takeaways ...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 3 days agoModerna is also evaluating mRNA-1345 in early-stage studies for high-risk adults, as well as...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 6 days agoRecap of the Week’s Most Important Stories Lilly’s CFO Departs: Lilly’s executive vice president and...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 7 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 3 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
BlackRock Favoring Growth Heading Into Second Half
ETF Trends via Yahoo Finance· 6 days agoThe BlackRock Target Allocation Team, which runs model portfolios followed by many advisors, turned even more bullish this week. Indeed, the current...
A Deep Dive into the New Amplify Weight Loss Drug & Treatment ETF (THNR) | Investing.com
Investing.com· 3 days agoETF investors are quick to jump from one trend to another, and the latest focus is on companies...